{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:24:33Z","timestamp":1792761873880,"version":"4.5.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2019,4,3]]},"DOI":"10.3233\/cbm-182182","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T16:17:50Z","timestamp":1552666670000},"page":"279-289","source":"Crossref","is-referenced-by-count":42,"title":["MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN"],"prefix":"10.1177","volume":"24","author":[{"given":"Jie","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyao","family":"Su","sequence":"additional","affiliation":[{"name":"Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjuan","family":"Shen","sequence":"additional","affiliation":[{"name":"Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiumin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linying","family":"Shi","sequence":"additional","affiliation":[{"name":"Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-182182_ref1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ng.556","article-title":"Subtle variations in Pten dose determine cancer susceptibility","volume":"42","author":"Alimonti","year":"2010","journal-title":"Nat Genet"},{"key":"10.3233\/CBM-182182_ref2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.3233\/CBM-182182_ref3","doi-asserted-by":"crossref","first-page":"521586","DOI":"10.1155\/2014\/521586","article-title":"MicroRNA: important player in the pathobiology of multiple myeloma","volume":"2014","author":"Bi","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.3233\/CBM-182182_ref4","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.4161\/cc.8.23.9994","article-title":"The microRNA-17-92 cluster: still a miRacle?","volume":"8","author":"Bonauer","year":"2009","journal-title":"Cell Cycle"},{"key":"10.3233\/CBM-182182_ref5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2003-04-1048","article-title":"Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation","volume":"103","author":"Brocke-Heidrich","year":"2004","journal-title":"Blood"},{"key":"10.3233\/CBM-182182_ref6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.leukres.2005.07.008","article-title":"Analysis of PTEN deletions and mutations in multiple myeloma","volume":"30","author":"Chang","year":"2006","journal-title":"Leuk Res"},{"key":"10.3233\/CBM-182182_ref7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2011.05.017","article-title":"miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma","volume":"309","author":"Chen","year":"2011","journal-title":"Cancer Lett"},{"key":"10.3233\/CBM-182182_ref8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.juro.2009.09.086","article-title":"The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma","volume":"183","author":"Chow","year":"2010","journal-title":"J Urol"},{"key":"10.3233\/CBM-182182_ref9","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-12-0191","article-title":"Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation","volume":"18","author":"de Larrea","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.3233\/CBM-182182_ref10","doi-asserted-by":"crossref","unstructured":"M.T. Di Martino, A. Gulla, M.E. Cantafio, M. Lionetti, E. Leone, N. Amodio, P.H. Guzzi, U. Foresta, F. Conforti, M. Cannataro, A. Neri, A. Giordano, P. Tagliaferri and P. Tassone, In vitro and in vivo anti-tumor activity of miR-221\/222 inhibitors in multiple myeloma, Oncotarget 4 (2013), 242\u2013255.","DOI":"10.18632\/oncotarget.820"},{"key":"10.3233\/CBM-182182_ref11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/ejh.12124","article-title":"Aberrant microRNA expression in multiple myeloma","volume":"91","author":"Dimopoulos","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.3233\/CBM-182182_ref12","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Galm","year":"2003","journal-title":"Blood"},{"key":"10.3233\/CBM-182182_ref13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.leukres.2012.08.021","article-title":"MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma","volume":"36","author":"Gao","year":"2012","journal-title":"Leuk Res"},{"key":"10.3233\/CBM-182182_ref14","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3109\/10428194.2010.528095","article-title":"Study of specific genetic and epigenetic variables in multiple myeloma","volume":"51","author":"Hatzimichael","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.3233\/CBM-182182_ref15","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","article-title":"A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation","volume":"65","author":"Hayashita","year":"2005","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-182182_ref16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.3233\/CBM-182182_ref17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2011.04.015","article-title":"Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN","volume":"308","author":"Heo","year":"2011","journal-title":"Cancer Lett"},{"key":"10.3233\/CBM-182182_ref18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12185-011-0917-5","article-title":"Novel therapies in MM: from the aspect of preclinical studies","volume":"94","author":"Hideshima","year":"2011","journal-title":"Int J Hematol"},{"key":"10.3233\/CBM-182182_ref19","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.3233\/CBM-182182_ref20","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-182182_ref21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.leukres.2015.04.010","article-title":"Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma","volume":"39","author":"Li","year":"2015","journal-title":"Leuk Res"},{"key":"10.3233\/CBM-182182_ref22","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.18632\/oncotarget.2761","article-title":"A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma","volume":"6","author":"Navarro","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-182182_ref23","doi-asserted-by":"crossref","unstructured":"F. Pichiorri, S.S. Suh, M. Ladetto, M. Kuehl, T. Palumbo, D. Drandi, C. Taccioli, N. Zanesi, H. Alder, J.P. Hagan, R. Munker, S. Volinia, M. Boccadoro, R. Garzon, A. Palumbo, R.I. Aqeilan and C.M. Croce, MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis, Proc Natl Acad Sci U S A 105 (2008), 12885\u201312890.","DOI":"10.1073\/pnas.0806202105"},{"key":"10.3233\/CBM-182182_ref24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/CBM-182182_ref25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/156800912802429300","article-title":"Molecular targets for the treatment of multiple myeloma","volume":"12","author":"Rossi","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"10.3233\/CBM-182182_ref26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"10.3233\/CBM-182182_ref27","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.2004.02.141","article-title":"The biology and clinical relevance of the PTEN tumor suppressor pathway","volume":"22","author":"Sansal","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-182182_ref28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3324\/haematol.2010.033845","article-title":"Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients","volume":"96","author":"Sarasquete","year":"2011","journal-title":"Haematologica"},{"key":"10.3233\/CBM-182182_ref29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2015.03.008","article-title":"Genomic heterogeneity in multiple myeloma","volume":"30","author":"Szalat","year":"2015","journal-title":"Curr Opin Genet Dev"},{"key":"10.3233\/CBM-182182_ref30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156800912802429292","article-title":"Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma","volume":"12","author":"Tassone","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"10.3233\/CBM-182182_ref31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12185-010-0604-y","article-title":"Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma","volume":"92","author":"Wang","year":"2010","journal-title":"Int J Hematol"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-182182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:06:54Z","timestamp":1777385214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-182182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":31,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/cbm-182182","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,3]]}}}